Eisai Co-promotes “PyloriTek® Test Kit”,
H. Pylori Infection Diagnostic Kit Launched by Sanko Junyaku
Sanko Junyaku Co., Ltd. (Headquarters: Tokyo, President: Masao Jimbo) today announced
that it will launch the PyloriTek® Test Kit, a diagnostic kit for detecting Helicobacter pylori (H.
pylori) infection in gastric biopsy specimens. The PyloriTek® Test Kit will be introduced to the
market by Sanko Junyaku in September 2007 in co-promotion with its parent company Eisai
Co., Ltd. (Headquarters: Tokyo, President and CEO: Haruo Naito)
H. pylori is a type of bacterium in the human stomach and has been known to be deeply
associated with peptic ulcers. The H. pylori eradication therapy has shown efficacy in reducing
the risk for ulcer recurrence, providing a great benefit for patients.
The PyloriTek® Test Kit is a diagnostic product used in the presumptive identification of H.
pylori infection before and after the eradication therapy to evaluate infectious status of the
patients. The PyloriTek® Test Kit shortens the diagnostic testing procedures due to the
simplified preparation, enabling the test to start at the earliest opportunity. In addition, easier
result evaluation can be made possible by the large reaction pad on which a positive reaction
Eisai Group established the Japan Business Headquarters in April 2007 which facilitates
provision of information, services and products under the business strategy unified by all four
domestic operations of Eisai Group (diagnostics/prescription pharmaceuticals/consumer
healthcare products/generics). Eisai Co., Ltd. which co-promotes the PyloriTek® Test Kit has
been marketing Pariet® (generic name: rabeprazole sodium), the company’s core proton
pump inhibitor which is approved for H. pylori eradication therapy in combination with
From diagnostics to treatment, Sanko Junyaku and Eisai provide a wide range of products and
information for H. pylori infection, thereby making further contributions to the treatment of
acid related disorders and improve the QOL (Quality of Life) of patients with peptic ulcers.
Name of the Product: PyloriTek® Test Kit (Helicobacter Pylori Urease Kit)
Intended Use: Detecting H. Pylori infection in gastric biopsy specimens
Shelf Life: 2 years after the manufacturing date (stored at 2 - 8°C)
Sample Testing Fee: 60 points per immunologic test for infectious disease
Biopsy diagnosing fee: 144 points per evaluation of immunologic test
Delivery Price: 12,900 yen / package containing 25 test strips
Manufactured by: Serim Research Corp. (U.S.A.)
Manufactured and marketed by: Sakura Finetek Japan Co., Ltd.
1-10-6 Iwamoto-cho, Chiyoda-ku, Tokyo, Japan
Manufacturing, marketing and import of in vitro
diagnostics, laboratory reagents, laboratory
5,262 million yen (50.59% owned by Eisai, as of March
4-6-10 Koishikawa, Bunkyo-ku, Tokyo, Japan
Research & development, manufacturing, marketing
and export and import of pharmaceuticals.
44,985 million yen (as of March 31, 2007)
IbuHXakut200mg_Ftbl_626438_148x620.qxp 10.12.2008 09:20 Seite 1 Gebrauchsinformation: Information für den Anwender IbuHEXAL® akut 200 mg Filmtabletten Zur Anwendung bei bei Kindern ab 6 Jahre, Jugendlichen und Erwachsenen Wirkstoff: Ibuprofen Lesen Sie die gesamte Packungsbeilage sorgfältig durch, bevor Sie mit der Einnahme die- ses Arzneimittels beginnen. Dieses Arzneimittel i
WEEKLY NEWS - 24 June 2005 << More of this week's news Cedants accuse reinsurers of irrational approach to German industrial business Sharply different views on the state of the market were voiced by industrial customers, primary insurers and reinsurers during apanel discussion organised by the insurance faculty of the Cologne University of Applied Science. Hermann Jörissen, boa